Fig. 6From: Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trialsThe pooled risk ratio (RR) of patients with treatment emergent adverse events (TEAEs) in different treatment doses compared with placebo, the diamond indicates the estimated RR with 95% confidence interval (CI) for the pooled patientsBack to article page